title: Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions.
abstract: We have used cerebral dialysis to monitor striatal metabolism of exogenously administered L-dopa (L-dihydroxyphenylalanine) in rats with unilateral lesions of the substantia nigra. The concentration of extracellular dopamine (DA) increased in both striata following L-dopa administration but the increase was markedly attenuated in the lesioned striatum. The formation of dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), the major DA metabolites, was also reduced in the lesioned striata following L-dopa administration; however, the reduction was not as great as was that of DA formation. A significant metabolism of exogenous L-dopa to 3-O-methyldopa occurred in both striata. L-dopa administration transiently increased extracellular levels of 5-hydroxyindoleacetic acid (5 HIAA) in both the lesioned and intact striata. These results suggest that the striatum with a reduction in DA nerve terminals is deficient both in the capacity to synthesize DA and in the storage mechanisms necessary to protect the newly synthesized DA from oxidative metabolism.
authors.affiliation: Department of Neurology, Mount Sinai School of Medicine, New York.
authors.forename: T
authors.initials: T
authors.lastname: Brannan
authors.forename: A
authors.initials: A
authors.lastname: Bhardwaj
authors.forename: J
authors.initials: J
authors.lastname: Martinez-Tica
authors.forename: J
authors.initials: J
authors.lastname: Weinberger
authors.forename: M
authors.initials: M
authors.lastname: Yahr
mesh_terms: D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D003342:Corpus Striatum / Q000378:metabolism* / Q000502:physiology; D004298:Dopamine / Q000378:metabolism*; D006719:Homovanillic Acid / Q000378:metabolism; D006892:Hydroxydopamines; D007980:Levodopa / Q000378:metabolism*; D008297:Male; D016627:Oxidopamine; D051381:Rats; D011919:Rats, Inbred Strains; D013378:Substantia Nigra / Q000502:physiology*
chemical_list: D006892:Hydroxydopamines; D015102:3,4-Dihydroxyphenylacetic Acid; D007980:Levodopa; D016627:Oxidopamine; D004298:Dopamine; D006719:Homovanillic Acid